好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | N4 - Neuroscience in the Clinic: Zika Virus: The Global Outbreak of a Neurotropic Virus

Tuesday 04/25/17
01:00 PM - 03:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Neuroscience in the Clinic Session
Allen J. Aksamit, Jr., MD, FAAN, Kiran Thakur, MD, FAAN
Infectious Disease
Participants should be more familiar with the risk factors, clinical and laboratory diagnosis of Zika virus and other emerging infections, and understand the advances in pathogenesis, therapies with their limitations, and prognosis. Participants will also learn of public health strategies and challenges to prevent the spread of future neurological outbreaks.
2.00 CME credits
Event Timeline
01:00 PM - 01:05 PM Luncheon Introduction
Omar Siddiqi, MD
01:00 PM - 01:15 PM Speaker Zika Case Presentation-Adult Manifestation
Kiran Thakur, MD, FAAN
01:00 PM - 03:00 PM Abstract 001 - Expanding Spectrum of Neurologic manifestations with Zika Virus Infection
Laura S. Surillo Dahdah, MD
01:00 PM - 03:00 PM Abstract 002 - Neuroviruses Emerging in the Americas Study (NEAS): The Colombian experience during the 2016 outbreak of Zika virus infection
01:15 PM - 01:45 PM Speaker Epidemiological Update
James J. Sejvar, MD, FAAN
01:45 PM - 02:15 PM Speaker Neurovirology and Neuropathogenesis
Carlos A. Pardo-Villamizar, MD
02:15 PM - 02:20 PM Speaker Introduction of Science Presentations
Allen J. Aksamit, Jr., MD, FAAN, Arun Venkatesan, MD, PhD
02:20 PM - 02:30 PM Speaker N4.001: Expanding Spectrum of Neurologic manifestations with Zika Virus Infection
Laura S. Surillo Dahdah, MD
02:30 PM - 02:40 PM Speaker N4.002: Neuroviruses Emerging in the Americas Study (NEAS): The Colombian experience during the 2016 outbreak of Zika virus infection
02:40 PM - 03:00 PM Speaker Panel Discussion
Faculty Disclosures
Allen J. Aksamit, Jr., MD, FAAN Dr. Aksamit has nothing to disclose.
Kiran Thakur, MD, FAAN Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. The institution of Dr. Thakur has received research support from Center for Disease Control and Prevention.
Arun Venkatesan, MD, PhD Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from MSRCF. The institution of Dr. Venkatesan has received research support from U.S. DOD.
Omar Siddiqi, MD The institution of Dr. Siddiqi has received research support from NIH.
James J. Sejvar, MD, FAAN Dr. Sejvar has nothing to disclose.
Carlos A. Pardo-Villamizar, MD The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Laura S. Surillo Dahdah, MD No disclosure on file
No disclosure on file
Marie B. Hidalgo, MD No disclosure on file
Gustavo E. Ramos, MD Dr. Ramos has nothing to disclose.
Sonia M. Caraballo-Cartagena, MD Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx.
Jose R. Carlo, MD, FAAN Dr. Carlo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for sanofi. Dr. Carlo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various insurance companies .
ANGELA GOMEZ No disclosure on file
Tania C. Zayas Torres, MD No disclosure on file
Lyda Osorio Lyda Osorio has nothing to disclose.
Beatriz Parra Beatriz Parra has nothing to disclose.
Paula Barreras, MD The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from 好色先生.
Marisel Vazquez, MD Dr. Vazquez has nothing to disclose.
Gonzalo Zuniga No disclosure on file
Jorge A. Angarita Diaz No disclosure on file
Guillermo Gonzalez-Manrique Guillermo Gonzalez-Manrique has nothing to disclose.
Gustavo Pradilla-Ardila, MD No disclosure on file
Carlos A. Luciano, MD, FAAN Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea Pharmaceuticals. Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for SIMED. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Universal Insurance Co.. Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pueblo Supermarket. The institution of Dr. Luciano has received research support from National Institutes of Health. The institution of Dr. Luciano has received research support from Catalyst Pharmaceuticals. Dr. Luciano has received personal compensation in the range of $100,000-$499,999 for serving as a Professor and Chair with University of Puerto Rico.
Maria I. Reyes-Mantilla, MD Dr. Reyes-Mantilla has nothing to disclose.
Cindy Beltran No disclosure on file
Anupama Kumar, PhD No disclosure on file
Jose Avila-Ornelas, MD Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. An immediate family member of Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Avila-Ornelas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Banner Pharmaceuticals.
David R. Cornblath, MD Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cigna. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MPTP. Dr. Cornblath has received intellectual property interests from a discovery or technology relating to health care.